Your browser doesn't support javascript.
loading
Loss of RBPMS in ovarian cancer compromises the efficacy of EGFR inhibitor gefitinib through activating HER2/AKT/mTOR/P70S6K signaling.
Li, Minzhen; Hu, Meng; Wang, Yanyun; Xia, Zhili; Li, Zhilong; Li, Juan; Zheng, Danxi; Zheng, Xuelian; Xi, Mingrong.
Afiliação
  • Li M; Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, 610000, China; Laboratory of Molecular and Translational Medicine, Sich
  • Hu M; State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, and Collaborative Innovation Center of Biotherapy, Chengdu, 610000, China.
  • Wang Y; Laboratory of Molecular and Translational Medicine, Sichuan University, Chengdu, 610000, China.
  • Xia Z; The First Clinical Medical College, Lanzhou University, Lanzhou, 730000, China.
  • Li Z; Laboratory of Molecular and Translational Medicine, Sichuan University, Chengdu, 610000, China.
  • Li J; Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, 610000, China; Laboratory of Molecular and Translational Medicine, Sich
  • Zheng D; Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, 610000, China; Laboratory of Molecular and Translational Medicine, Sich
  • Zheng X; Laboratory of Molecular and Translational Medicine, Sichuan University, Chengdu, 610000, China.
  • Xi M; Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, 610000, China. Electronic address: xmrjzz@126.com.
Biochem Biophys Res Commun ; 637: 348-357, 2022 12 31.
Article em En | MEDLINE | ID: mdl-36423381
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Proteínas de Ligação a RNA / Gefitinibe / Carcinoma Epitelial do Ovário Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Proteínas de Ligação a RNA / Gefitinibe / Carcinoma Epitelial do Ovário Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article